Study of cox-2 inhibitors could lead to new class of stroke drugs
Monday, October 3, 2011 - 11:02
in Health & Medicine
A study, in mice, by investigators at the Stanford University School of Medicine points toward potential new therapies for stroke, the nation's third-leading cause of death and foremost single cause of severe neurological disability. The study, which will be published online Oct. 3 in the Journal of Clinical Investigation, also may reveal why a much-heralded class of blockbuster drugs failed to live up to their promise.